Larson Financial Group’s Direxion Daily Healthcare Bull 3X ETF CURE Stock Holding History

Larson Financial Group’s Portfolio CURE Stock Details CURE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$319K	Buy	+2,847	New	+$268K	0.01%	683

Other funds holding CURE

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

TCM

Traynor Capital Management Malvern, Pennsylvania $2.18B AUM 62.36% 1-Year Est. Return

Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return

OBWG

Onyx Bridge Wealth Group Tarrytown, New York $1.11B AUM 24.65% 1-Year Est. Return

StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Larson Financial Group's CURE Position: Q2 2026 in Review

Larson Financial Group opened a new position in Direxion Daily Healthcare Bull 3X ETF (CURE) in Q2 2026: 2,847 shares worth $319K. The stake represents 0.01% of the portfolio and ranks #683 among its holdings.

19 funds tracked by Wall St. Rank hold CURE as of Q2 2026.

Larson Financial Group held 2,847 shares of Direxion Daily Healthcare Bull 3X ETF worth $319K as of Q2 2026.
Direxion Daily Healthcare Bull 3X ETF was a new Larson Financial Group position in Q2 2026.
Direxion Daily Healthcare Bull 3X ETF made up 0.01% of Larson Financial Group's portfolio in Q2 2026, its #683 holding.
19 funds tracked by Wall St. Rank held Direxion Daily Healthcare Bull 3X ETF as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.